Keyword Analysis & Research: endocrine therapy
Keyword Research: People who searched endocrine therapy also searched
Search Results related to endocrine therapy on Search Engine
-
Hormone therapy for breast cancer - Mount Sinai Health System
https://www.mountsinai.org/health-library/special-topic/hormone-therapy-for-breast-cancer
Dec 6, 2021 · Hormone therapy to treat breast cancer uses drugs or treatments to lower levels or block the action of female sex hormones (estrogen and progesterone) in a woman's body. This helps slow the growth of many breast cancers. Hormone therapy makes cancer less likely to return after breast cancer surgery.
DA: 6 PA: 17 MOZ Rank: 81
-
Endocrine Cancer: Diagnosis & Treatment | NewYork-Presbyterian
https://www.nyp.org/cancer/endocrine-cancer/treatment
Biopsy. Blood tests. Endocrine Treatments We Offer. NewYork-Presbyterian's endocrine cancer experts create a unique treatment plan for each patient based on the type of cancer, the tumor size, and whether the cancer cells have metastasized.
DA: 26 PA: 6 MOZ Rank: 53
-
Updates in endocrine therapy for metastatic breast cancer
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832960/
Feb 2, 2022 · Endocrine therapy (ET) is the foundation of treatment for patients with breast cancer driven by expression of estrogen receptor (ER) and/or progesterone receptor (PR) 1. This practice dates back to the late 19th century when George Beatson reported that the removal of ovaries improved outcomes for young women with advanced breast cancer 2.
DA: 97 PA: 65 MOZ Rank: 7
-
Endocrinology - Conditions treated - Mayo Clinic
https://www.mayoclinic.org/departments-centers/endocrinology/sections/conditions-treated/orc-20392634
Nov 2, 2019 · Mayo Clinic endocrinologists are equipped to treat a range of endocrine disorders and dysfunctions. Many people come to Mayo Clinic when their condition is unusual or complex. You may come to Mayo Clinic on your own or with a referral from your primary care doctor.
DA: 20 PA: 10 MOZ Rank: 20
-
Ribociclib plus Endocrine Therapy in Early Breast Cancer
https://www.nejm.org/doi/full/10.1056/NEJMoa2305488
Hormone receptor (HR)–positive, human epidermal growth factor receptor 2 (HER2)–negative breast cancer is the most common subtype of breast cancer, accounting for 70 to 75% of cases. 1 The ...
DA: 54 PA: 9 MOZ Rank: 30
-
Advances in endocrine therapy for breast cancer: considering
https://pubmed.ncbi.nlm.nih.gov/15637958/
Endocrine therapy is the standard of care for most women with hormone receptor-positive tumors in adjuvant and metastatic settings. The selective estrogen response modifier tamoxifen has been the standard treatment for postmenopausal patients for many years.
DA: 5 PA: 19 MOZ Rank: 46
-
Breast Cancer Index Deemed “Important” for Clinical Practice
https://www.cancertherapyadvisor.com/home/cancer-topics/breast-cancer/breast-cancer-index-clinical-practice/
1 day ago · The questionnaire results showed that, after Breast Cancer Index testing, physicians changed their recommendations regarding extended endocrine therapy in 40.1% of patients (P <.0001).Extended ...
DA: 8 PA: 54 MOZ Rank: 82
-
Endocrine therapy resistance: what we know and future directions
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446423/
Aug 31, 2022 · Endocrine resistance is a major hurdle in the treatment of estrogen receptor (ER)-positive breast cancer. When abnormally regulated, molecular signals responsible for cellular proliferation, as well as ER itself, allow for cellular evasion of ER-dependent treatments.
DA: 72 PA: 94 MOZ Rank: 67
-
An emerging generation of endocrine therapies in breast cancer: …
https://pubmed.ncbi.nlm.nih.gov/37019913/
Apr 5, 2023 · Anti-estrogen therapy is a key component of the treatment of both early and advanced-stage hormone receptor (HR)-positive breast cancer. This review discusses the recent emergence of several anti-estrogen therapies, some of which were designed to overcome common mechanisms of endocrine resistance. T …
DA: 75 PA: 63 MOZ Rank: 38
-
Endocrine therapy for advanced breast cancer - PubMed
https://pubmed.ncbi.nlm.nih.gov/25003351/
The demonstrated efficacy of pharmacologic antiestrogen therapy in treating hormone receptor-positive breast cancer has changed the landscape of treatment for the majority of women with metastatic disease, providing them with a well-tolerated therapeutic alternative to surgical oophorectomy and chemotherapy.
DA: 41 PA: 73 MOZ Rank: 74